Inactivated hepatitis A vaccine

BIOLOGICAL5 trials

Sponsors

Novartis Vaccines, Siriraj Hospital, Boryung Pharmaceutical Co., Ltd, Sinovac Research and Development Co., Ltd.

Conditions

COVID-19EncephalitisHepatitis AHepatitis A VaccineHepatitis BMeningococcal DiseaseMeningococcal Meningitis

Phase 3

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

CompletedNCT01453348

Novartis VaccinesHepatitis A, Hepatitis B, Meningococcal Disease +1

Start: 2011-10-31End: 2012-01-31Updated: 2017-06-08

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)

CompletedNCT03654677

Boryung Pharmaceutical Co., LtdHepatitis A Vaccine

Start: 2017-09-19End: 2019-01-31Updated: 2025-05-22

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine

CompletedNCT03654664

Boryung Pharmaceutical Co., LtdHepatitis A Vaccine

Start: 2017-06-20End: 2019-06-24Updated: 2023-07-07

Phase 4

Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX

CompletedNCT02526550

Siriraj HospitalEncephalitis

Start: 2014-06-30End: 2014-07-31Updated: 2016-12-07

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

CompletedNCT04953325

Sinovac Research and Development Co., Ltd.COVID-19

Start: 2021-07-09End: 2022-01-31Updated: 2022-04-14

Related Papers

Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults

Journal of Travel Medicine2014-12-0913 citations